HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 129.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,750 shares of the company’s stock after buying an additional 988 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in HCA Healthcare were worth $526,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Evergreen Private Wealth LLC grew its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock valued at $3,838,000 after buying an additional 35 shares in the last quarter. First Horizon Advisors Inc. grew its stake in shares of HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after buying an additional 36 shares in the last quarter. Mediolanum International Funds Ltd grew its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after buying an additional 36 shares in the last quarter. Hartford Funds Management Co LLC boosted its holdings in HCA Healthcare by 1.6% in the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after purchasing an additional 39 shares during the period. Finally, Prairie Wealth Advisors Inc. boosted its holdings in HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after purchasing an additional 40 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent research reports. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Finally, KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $330.11 on Friday. The stock has a market capitalization of $81.27 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock’s 50-day moving average price is $316.70 and its 200 day moving average price is $347.49. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the firm posted $5.90 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare’s payout ratio is presently 13.11%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.